Sponsors and Exhibitors

Gold Sponsor

American Hospital


sanofi


image


Silver Sponsors

Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.

An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion.

Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing mankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.


novartis_logrgb

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more


amgen-logo-2

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its manufacturing expertise to strive for solutions dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.


msd

MSD also known as Merck Sharp & Dohme Corp., (a subsidiary of Merck & Co., Inc.,Whitehouse Station, NJ, USA) is a global research-driven pharmaceutical companydedicated to putting patients first. Established in 1891, MSD discovers, develops,manufactures and markets vaccines and medicines to address unmet medical needs.MSD has been present for over than 30 years in the GULF region. MSD GULF operatesthroughout offices based in the UAE, Kuwait, Bahrain, Qatar & Oman and ranksamongst the leading pharmaceutical companies throughout the GULF region. Throughits local distributors, MSD GULF provides innovative medications in several diseaseentities. These include products for Anti- Infectives, Cardiovascular, Asthma & Allergy,Diabetes, HCV, HIV, Pain & Inflammation, Osteoporosis, Oncology, Fertility,Ophthalmic, and Anesthesia in addition to several specialized Vaccines.


To provide state of the art technology and solutions to the healthcare industry in Saudi Arabia and the GCC, and work closely with medical practitioners to contribute to patient care.

To play an active role in developing skills of healthcare providers with the support of our suppliers.

To evaluate market needs, adapt to changing demands, and continuously enrich our portfolio to effectively focus corporate assets in the service of various disciplines, thus enabling healthy growth.

To continue our commitment to offer premium and unique services and ensure ultimate levels of customer satisfaction by recruiting, developing, motivating, and rewarding highly qualified personnel who demonstrate exceptional levels of professionalism and dedication.

We believe that making a sale is not the end, but the beginning of a long lasting relationship which is prized above all.


Roche have taken the unprecedented move of being the first IVD company to have a Management Center and a logistics hub in the Middle East. Roche has extended its ownership of the entire supply chain, quality control and customer support all the way into the centre of the region. This base of operations reinforces the commitment to global Roche standards and is driven by a full team of vastly experienced specialists offering a complete portfolio of services. With this regional empowerment, Roche has moved its leadership and decision-making closer to its customers and distributors. These investments allow Roche Diagnostics Middle East to develop from being a supplier into becoming the preferred IVD partner for its customers.

Roche Diagnostics Middle East offers a complete portfolio of services in 16 countries: UAE, Saudi Arabia, Iraq, Iran, Qatar, Kuwait, Bahrain, Oman, Yemen, Syria, Jordan, Palestine, Lebanon, Egypt, Libya and Maldives. For more information, please visit www.roche-middleeast.com


 

Bronze Sponsors

Julphar

Julphar is the largest generic pharmaceutical manufacturer in MENA. For over thirty years, we have been providing high quality, affordable medicines to families across the region. We operate thirteen internationally accredited facilities in the UAE and others located in Ethiopia, Bangladesh and KSA. We maintain a large and diverse range of medicines targeting major therapeutic segments, inclusive of biotechnology. Our strong network ensures distribution to over 40 countries worldwide.